NASDAQ:MITO - Stealth BioTherapeutics Price Target & Analyst Ratings

+0.03 (+0.26 %)
(As of 07/22/2019 01:15 PM ET)
Today's Range
Now: $11.3815
50-Day Range
MA: $12.38
52-Week Range
Now: $11.3815
Volume680 shs
Average Volume3,259 shs
Market Capitalization$318.00 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Stealth BioTherapeutics (NASDAQ:MITO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Stealth BioTherapeutics in the last 12 months. Their average twelve-month price target is $26.60, suggesting that the stock has a possible upside of 133.71%. The high price target for MITO is $35.00 and the low price target for MITO is $16.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 2.802.802.75N/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.60$26.60$25.75N/A
Price Target Upside: 133.71% upside116.97% upside71.44% upsideN/A

Stealth BioTherapeutics (NASDAQ:MITO) Consensus Price Target History

Stealth BioTherapeutics (NASDAQ:MITO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2019HC WainwrightReiterated RatingBuy$30.00HighView Rating Details
3/12/2019Jefferies Financial GroupInitiated CoverageHold ➝ Hold$16.00HighView Rating Details
3/12/2019NomuraInitiated CoverageBuy ➝ Buy$23.00HighView Rating Details
3/12/2019Evercore ISIInitiated CoverageOutperform ➝ Outperform$35.00HighView Rating Details
3/12/2019BMO Capital MarketsInitiated CoverageOutperform$29.00HighView Rating Details
(Data available from 7/22/2017 forward)
This page was last updated on 7/22/2019 by Staff

Featured Article: Leveraged Buyout (LBO)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel